Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 4 , Pages 307-317 , July 2009

Markers of Alzheimer's disease in a population attending a memory clinic

  • Giovanni B. Frisoni

      Affiliations

    • Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
    • Psychogeriatric Ward, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
    • Corresponding Author InformationCorresponding author. Tel.: 39-030-3501361.
  • ,
  • Annapaola Prestia

      Affiliations

    • Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Orazio Zanetti

      Affiliations

    • Alzheimer Unit, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Samantha Galluzzi

      Affiliations

    • Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Melissa Romano

      Affiliations

    • Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Maria Cotelli

      Affiliations

    • Laboratory of the Neuropsychology Cognitive Neuroscience Unit, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Massimo Gennarelli

      Affiliations

    • Genetics Unit, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
    • Division of Biology and Genetics, Department of Biomedical Sciences and Biotechnologies, University of Brescia, Brescia, Italy
  • ,
  • Giuliano Binetti

      Affiliations

    • NeuroBioGen Laboratory Memory Clinic, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Luisella Bocchio

      Affiliations

    • Genetics Unit, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Barbara Paghera

      Affiliations

    • Nuclear Medicine Service, Spedali Civili of Brescia, Brescia, Italy
  • ,
  • Giovanni Amicucci

      Affiliations

    • Service of Anesthesiology, S. Orsola-Fatebenefratelli Hospital, Brescia, Italy
  • ,
  • Matteo Bonetti

      Affiliations

    • Service of Neuroradiology, Istituto Clinico Città di Brescia, Brescia, Italy
  • ,
  • Luisa Benussi

      Affiliations

    • NeuroBioGen Laboratory Memory Clinic, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Roberta Ghidoni

      Affiliations

    • NeuroBioGen Laboratory Memory Clinic, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
    • Proteomics Unit, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
  • ,
  • Cristina Geroldi

      Affiliations

    • Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy
    • Psychogeriatric Ward, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy

References 

  1. Robertson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science. 2006;314:781–784
  2. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–1992
  3. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308
  4. Petersen RC, Parisi JE, Dickson DW, Johnson KA, Knopman DS, Boeve BF, et al. Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol. 2006;63:665–672
  5. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397–405
  6. Arai H, Higuchi S, Sasaki H. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease. Gerontology. 1997;43:2–10
  7. Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry. 2007;22:563–567
  8. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198–205
  9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  10. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734–746
  11. Cockrell JR, Folstein MF. Mini-Mental State Examination (MMSE). Psychopharmacol Bull. 1988;24:689–692
  12. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–186
  13. De Leo D, Frisoni GB, Rozzini R, Trabucchi M. Italian community norms for the Brief Symptom Inventory in the elderly. Br J Clin Psychol. 1993;32:209–213
  14. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbei J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308–2314
  15. Lezak M, Howieson D, Loring DW. Neuropsychological Assessment. 4th ed.. Oxford: Oxford University Press; 2004;
  16. McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9:417–423
  17. Knopman DS, Boeve BF, Petersen RC. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc. 2003;78:1290–1308
  18. Erkinjuntti T. Clinical criteria for vascular dementia: the NINDS-AIREN criteria. Dementia. 1994;5:189–192
  19. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56:33–39
  20. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol. 2001;58:1803–1809
  21. Collins DL, Neelin P, Peters TM, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994;18:192–205
  22. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55:967–972
  23. Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21–93 years of age: establishment of reference values. Clin Chem. 2001;47:1776–1781
  24. Valk J, Barkof T, Scheltens P. Magnetic Resonance in Dementia. Berlin: Springer Verlag; 2002;
  25. Frisoni GB, Scheltens P, Galluzzi S, Nobili FM, Fox NC, Robert PH, et al. Neuroimaging tools to rate regional atrophy, subcortical cerebrovascular disease, and regional cerebral blood flow and metabolism: consensus paper of the EADC. J Neurol Neurosurg Psychiatry. 2003;74:1371–1381
  26. O'Brien TJ, Newton MR, Cook MJ, Berlangieri SU, Kilpatrick C, Morris K, et al. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia. 1997;38:74–80
  27. Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage. 1999;9:63–80
  28. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17:302–316
  29. Zetterberg H, Wahlund LO, Blennow K. Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci Lett. 2003;352:67–69
  30. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2003;2:605–613
  31. van Norden AG, Fick WF, de Laat KF, van Uden IW, van Oudheusden LJ, Tendolkar I, et al. Subjective cognitive failures and hippocampal volume in elderly with white matter lesions. Neurology. 2008;71:1152–1159
  32. St John P, Montgomery P. Are cognitively intact seniors with subjective memory loss more likely to develop dementia?. Int J Geriatr Psychiatry. 2002;17:814–820
  33. Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA. Parkinson's disease is associated with hippocampal atrophy. Mov Disord. 2003;18:784–790
  34. Hashimoto M, Kitagaki H, Imamura T, Hirono N, Shimomura T, Kazui H, et al. Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study. Neurology. 1998;51:357–362
  35. Frisoni GB, Laakso MP, Beltramello A, Geroldi C, Bianchetti A, Soininen H, et al. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology. 1999;52:91–100
  36. Frisoni GB, Padovani A, Wahlund LO. The diagnosis of Alzheimer disease before it is Alzheimer dementia. Arch Neurol. 2003;60:1023–1024
  37. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret C, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–1599
  38. Petersen RC, Negash S. Mild cognitive impairment: an overview. CNS Spectr. 2008;13:45–53
  39. Jagust W, Reed B, Mungas D, Ellis W, Decarli C. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?. Neurology. 2007;69:871–877
  40. Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001;286:2120–2127
  41. Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med. 2000;41:1920–1928
  42. Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2003;2:605–613
  43. Brandt C, Bahl J, Heegaard NHH, Waldemar G, Johannsen P. Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic. Dement Geriatr Cogn Disord. 2008;25:553–558
  44. Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, et al. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment. Dement Geriatr Cogn Disord. 2007;23:316–320
  45. Hoyer J, Becker ES, Neumer S, Soeder U, Margraf J. Screening for anxiety in an epidemiological sample: predictive accuracy of questionnaires. J Anxiety Disord. 2002;16:113–134
  46. Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, et al. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. Pregnancy Childbirth. 2008;8:33
  47. Butcher J. Alzheimer's researchers open the doors to data sharing. Lancet Neurol. 2007;6:480–481
  48. Lewczuk P, Kornhuber J, Vanderstichele H, Vanmechelen E, Esselmann H, Bibl M, et al. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study. Neurobiol Aging. 2008;29:812–818
  49. Colliot O, Chételat G, Chupin M, Desgranges B, Magnin B, Benali H, et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology. 2008;248:194–201
  50. Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage. 1999;9:63–80

PII: S1552-5260(09)00102-2

doi: 10.1016/j.jalz.2009.04.1235

Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Volume 5, Issue 4 , Pages 307-317 , July 2009